CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- DEF 14A Proxy Proxy Statement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Strategy/Bus Ops Officer sold 11,000 shares at $6.56 ($72,134)
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
Page 8 of 18 · 356 filings